CMB 25.0% 0.5¢ cambium bio limited

Ann: US Patent for Sygenus, page-2

  1. TDA
    11,411 Posts.
    lightbulb Created with Sketch. 137
    More patents for Sygenus, I really like the last line which shows not only is Progenza landing licensing agreements but Sygenus could be to follow soon enough!

    “We will now focus our investment in pre-clinical proof of concept activities and securing partnerships for in-human studies and commercialisation in the U.S. Our commercial partnership discussions continue, and we’re pleased to have received significant interest from around the world
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $3.83M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $2.629K 533.9K

Buyers (Bids)

No. Vol. Price($)
7 1617192 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 746300 6
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.